Cargando…
Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
Information on treatment of COVID-19 infection in renal transplant recipients is scarce, especially in symptomatic patients and patients with recent major clinical events. This group of patients suffers from different opportunistic infections which may coexist with COVID-19. Currently available expe...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261461/ https://www.ncbi.nlm.nih.gov/pubmed/32563969 http://dx.doi.org/10.1016/j.mehy.2020.109903 |